PANCREATIC CANCER RESEARCH FUND
The charity offers project grants for pancreatic cancer research to researchers in the UK and Ireland.
Financial health, per its FY2025 accounts
The accounts state that unrestricted funds increased to £5,379,991, driven by a net income of £735,927 which included significant investment returns. The charity is winding down its active grant-making and fundraising operations, with the Chief Executive continuing part-time to administer existing commitments and the Tissue Bank until at least 2027. The trustees confirm that reserves are sufficient to cover the full cost of current awards, minimizing risk as income is expected to decrease.
What the accounts disclose
“The trustees have agreed that research awards will only be offered if the full cost of the award is already available in the charity’s funds. This will minimise risk and ensure continuity for each research project should the charity’s income be dramatically reduced. Reserves, therefore, cover the full cost of awards allocated in each annual award round.” — page 4
Leadership, per the charity’s website
- Jo Hansford — Patron
- Professor Hemant Kocher — Director, PCRF Tissue Bank
Structured financials (annual return, FY ending 30/11/2025)
Trustees
- BRIAN RAPER
- MARGARET BLANKS
- MARGARET BLANKS
- Peter Joseph Michael Blanks
- Stephen Henry Collen
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/11/2025 | £1.5m | £750k |
| 30/11/2024 | £946k | £829k |
| 30/11/2023 | £1.5m | £660k |
| 30/11/2022 | £1.4m | £1.5m |
| 30/11/2021 | £1.4m | £2.2m |
Common questions
Is PANCREATIC CANCER RESEARCH FUND financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted funds increased to £5,379,991, driven by a net income of £735,927 which included significant investment returns. The charity is winding down its active grant-making and fundraising operations, with the Chief Executive continuing part-time to administer existing commitments and the Tissue Bank until at least 2027. The trustees confirm that reserves are sufficient to cover the full cost of current awards, minimizing risk as income is expected to decrease. Its FY2025 accounts were audited by Grant Harrod Lerman Davis LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| PILKINGTON CHARITIES FUND | 3 | £32k |
| EDITH MURPHY FOUNDATION | 2 | £331k |
| THE ORR MACKINTOSH FOUNDATION LIMITED | 2 | £275k |
| THE CATHERINE COOKSON CHARITABLE TRUST | 2 | £260k |
| ROBERT LUFF FOUNDATION LIMITED | 2 | £100k |
| CECIL PILKINGTON CHARITABLE TRUST | 2 | £47k |
| SIR SAMUEL SCOTT OF YEWS TRUST | 2 | £45k |
| THE INMAN CHARITY | 2 | £19k |
Charities like this
- PANCREATIC CANCER UK
- PLUM LAYTON CHARITABLE TRUST
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- CANCER RESEARCH UK
- CANCER RESEARCH WALES
- THE BIG C APPEAL LIMITED
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| PANCREATIC CANCER RESEARCH FUND | £1.5m | — | 0 | unclear | — | no doubt |
| PANCREATIC CANCER UK | £13.7m | — | — | unclear | 42.0% | no doubt |
| PLUM LAYTON CHARITABLE TRUST | £124k | — | 0 | above | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |
| CANCER RESEARCH UK | £734.8m | — | 380 | above | 22.0% | no doubt |
| CANCER RESEARCH WALES | £5.9m | — | — | unclear | — | no doubt |